Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. KRT79 - Wikipedia
KRT79 - Wikipedia
From Wikipedia, the free encyclopedia
KRT79
Identifiers
AliasesKRT79, K6L, KRT6L, keratin 79
External IDsOMIM: 611160; MGI: 2385030; HomoloGene: 89169; GeneCards: KRT79; OMA:KRT79 - orthologs
Gene location (Human)
Chromosome 12 (human)
Chr.Chromosome 12 (human)[1]
Chromosome 12 (human)
Genomic location for KRT79
Genomic location for KRT79
Band12q13.13Start52,821,408 bp[1]
End52,834,311 bp[1]
Gene location (Mouse)
Chromosome 15 (mouse)
Chr.Chromosome 15 (mouse)[2]
Chromosome 15 (mouse)
Genomic location for KRT79
Genomic location for KRT79
Band15|15 F2Start101,837,767 bp[2]
End101,848,759 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • skin of thigh

  • vulva

  • skin of abdomen

  • nipple

  • subcutaneous adipose tissue

  • mammary gland

  • lactiferous gland

  • upper lobe of left lung

  • right lung

  • islet of Langerhans
Top expressed in
  • lip

  • skin of external ear

  • skin of back

  • right lung lobe

  • mucous cell of stomach

  • skin of abdomen

  • sexually immature organism

  • epidermis

  • conjunctival fornix

  • embryo
More reference expression data
BioGPS
n/a
Gene ontology
Molecular function
  • enzyme binding
  • protein binding
  • structural molecule activity
Cellular component
  • keratin filament
  • extracellular exosome
  • intermediate filament
  • cytosol
Biological process
  • keratinization
  • cornification
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

338785

223917

Ensembl

ENSG00000185640

ENSMUSG00000061397

UniProt

Q5XKE5

Q8VED5

RefSeq (mRNA)

NM_175834

NM_146063

RefSeq (protein)

NP_787028

NP_666175

Location (UCSC)Chr 12: 52.82 – 52.83 MbChr 15: 101.84 – 101.85 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Keratin 79 also known as KRT79 is a protein which humans is encoded by the KRT79 gene.[5][6]

Function

[edit]

Keratins, such as KRT79, are filament proteins that make up one of the major structural fibers of epithelial cells[7]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000185640 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000061397 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Hesse M, Magin TM, Weber K (July 2001). "Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18". J. Cell Sci. 114 (Pt 14): 2569–75. doi:10.1242/jcs.114.14.2569. PMID 11683385.
  6. ^ "Entrez Gene: KRT79 keratin 79".
  7. ^ Rogers MA, Edler L, Winter H, Langbein L, Beckmann I, Schweizer J (March 2005). "Characterization of new members of the human type II keratin gene family and a general evaluation of the keratin gene domain on chromosome 12q13.13". J. Invest. Dermatol. 124 (3): 536–44. doi:10.1111/j.0022-202X.2004.23530.x. PMID 15737194.

Further reading

[edit]
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2002). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
  • Sowa ME, Bennett EJ, Gygi SP, Harper JW (2009). "Defining the human deubiquitinating enzyme interaction landscape". Cell. 138 (2): 389–403. doi:10.1016/j.cell.2009.04.042. PMC 2716422. PMID 19615732.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.


  • v
  • t
  • e
Proteins of the cytoskeleton
Human
Microfilaments
and ABPs
Myofilament
Actins
  • A1
  • A2
  • B
  • C1
  • G1
  • G2
Myosins
  • I
    • MYO1A
    • MYO1B
    • MYO1C
    • MYO1D
    • MYO1E
    • MYO1F
    • MYO1G
    • MYO1H)
  • II
    • MYH1
    • MYH2
    • MYH3
    • MYH4
    • MYH6
    • MYH7
    • MYH7B
    • MYH8
    • MYH9
    • MYH10
    • MYH11
    • MYH13
    • MYH14
    • MYH15
    • MYH16
  • III
    • MYO3A
    • MYO3B
  • V
    • MYO5A
    • MYO5B
    • MYO5C
  • VI
    • MYO6
  • VII
    • MYO7A
    • MYO7B
  • IX
    • MYO9A
    • MYO9B
  • X
    • MYO10
  • XV
    • MYO15A
  • XVIII
    • MYO18A
    • MYO18B
  • LC
    • MYL1
    • MYL2
    • MYL3
    • MYL4
    • MYL5
    • MYL6
    • MYL6B
    • MYL7
    • MYL9
    • MYLIP
    • MYLK
    • MYLK2
    • MYLL1
Other
  • Tropomodulin
    • 1
    • 2
    • 3
    • 4
  • Troponin
    • T 1 2 3
    • C 1 2
    • I 1 2 3
  • Tropomyosin
    • 1
    • 2
    • 3
    • 4
  • Actinin
    • 1
    • 2
    • 3
    • 4
  • Arp2/3 complex
  • actin depolymerizing factors
    • Cofilin
      • 1
      • 2
    • Destrin
  • Gelsolin
  • Profilin
    • 1
    • 2
  • Titin
Other
  • Wiskott–Aldrich syndrome protein
  • Fibrillin
  • Filamin
    • FLNA
    • FLNB
    • FLNC
  • Espin
  • TRIOBP
Intermediate
filaments
Type 1/2
(Keratin,
Cytokeratin)
Epithelial keratins
(soft alpha-keratins)
  • type I/chromosome 17
    • 9
    • 10
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 19
    • 20
  • chromosome 12
    • 18
  • none
    • 21
  • type II/chromosome 12
    • 1
    • 2A
    • 3
    • 4
    • 5
    • 6A
    • 6B
    • 6C
    • 7
    • 8
Hair keratins
(hard alpha-keratins)
  • type I/chromosome 17
    • 31
    • 32
    • 33A
    • 33B
    • 34
    • 35
    • 36
    • 37
    • 38
  • type II/chromosome 12
    • 81
    • 82
    • 83
    • 84
    • 85
    • 86
Ungrouped alpha
  • chromosome 17
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 39
    • 40
  • chromosome 12
    • 71
    • 72
    • 73
    • 74
    • 75
    • 76
    • 77
    • 78
    • 79
    • 80
Not alpha
  • Beta-keratin
Type 3
  • Desmin
  • GFAP
  • Peripherin
  • Vimentin
Type 4
  • Internexin
  • Nestin
  • Neurofilament
    • NEFL
    • NEFM
    • NEFH
  • Synemin
  • Syncoilin
Type 5
  • Nuclear lamins: A/C
  • B1
  • B2
Microtubules
and MAPs
Tubulins
  • TUBA1A
  • TUBA1B
  • TUBA1C
  • TUBA3C
  • TUBA3D
  • TUBA3E
  • TUBA4A
  • TUBA8
  • TUBB
  • TUBB1
  • TUBB2A
  • TUBB2B
  • TUBB2C
  • TUBB3
  • TUBB4
  • TUBB4Q
  • TUBB6
  • TUBB8
  • TUBG1
  • TUBG2
  • TUBGCP2
  • TUBGCP3
  • TUBGCP4
  • TUBGCP5
  • TUBGCP6
  • TUBD1
  • TUBE1
MAPs
  • EB1
  • EB2
  • EB3
  • MAP1A
  • MAP1B
  • MAP2
  • MAP4
Kinesins
  • KIF1A
  • KIF1B
  • KIF2A
  • KIF2C
  • KIF3B
  • KIF3C
  • KIF4A
  • KIF4B
  • KIF5A
  • KIF5B
  • KIF5C
  • KIF6
  • KIF7
  • KIF9
  • KIF11
  • KIF12
  • KIF13A
  • KIF13B
  • KIF14
  • KIF15
  • KIF16B
  • KIF17
  • KIF18A
  • KIF18B
  • KIF19
  • KIF20A
  • KIF20B
  • KIF21A
  • KIF21B
  • KIF22
  • KIF23
  • KIF24
  • KIF25
  • KIF26A
  • KIF26B
  • KIF27
  • KIFC1
  • KIFC2
  • KIFC3
Dyneins
  • axonemal: DNAH1
  • DNAH2
  • DNAH3
  • DNAH5
  • DNAH6
  • DNAH7
  • DNAH8
  • DNAH9
  • DNAH10
  • DNAH11
  • DNAH12
  • DNAH13
  • DNAH14
  • DNAH17
  • DNAI1
  • DNAI2
  • DNALI1
  • DNAL1
  • DNAL4
  • cytoplasmic: DYNC1H1
  • DYNC2H1
  • DYNC1I1
  • DYNC1I2
  • DYNC1LI1
  • DYNC1LI2
  • DYNC2LI1
  • DYNLL1
  • DYNLL2
  • DYNLRB1
  • DYNLRB2
  • DYNLT1
  • DYNLT3
Microtubule organising proteins
  • CAMSAP1
  • CAMSAP2
  • CAMSAP3
  • Centrin 1
  • Centrin 2
  • Centrin 3
  • PCM1
Microtubule severing proteins
  • Katanin
  • Spastin
Other
  • Tau protein
  • Dynactin
    • DCTN1
  • Stathmin
  • Tektin
    • TEKT1
    • TEKT2
    • TEKT3
    • TEKT4
    • TEKT5
  • Dynamin
    • DNM1
    • DNM2
    • DNM3
Catenins
  • Alpha catenin
  • Beta catenin
    • APC
  • Plakoglobin (gamma catenin)
  • Delta catenin
  • GAN
Membrane
  • Dystrophin
    • Dystroglycan
  • Utrophin
  • Ankyrin
    • ANK1
    • ANK2
    • ANK3
  • Spectrin
    • SPTA1
    • SPTAN1
    • SPTB
    • SPTBN1
    • SPTBN2
    • SPTBN4
    • SPTBN5
Other
  • Plakins
    • Corneodesmosin
    • Desmoplakin
    • Dystonin
    • Envoplakin
    • MACF1
    • Periplakin
    • Plectin
  • Talin
    • TLN1
  • Vinculin
  • Plakophilin
    • PKP1
    • PKP2
  • ACF7
  • PLEKHA7
Nonhuman
  • Major sperm proteins
  • Prokaryotic cytoskeleton
    • Crescentin
    • FtsZ
    • MreB
    • ParM
See also: cytoskeletal defects


Stub icon

This article on a gene on human chromosome 12 is a stub. You can help Wikipedia by adding missing information.

  • v
  • t
  • e
Retrieved from "https://teknopedia.ac.id/w/index.php?title=KRT79&oldid=1300572894"
Categories:
  • Genes on human chromosome 12
  • Human chromosome 12 gene stubs
Hidden categories:
  • Wikipedia articles incorporating text from the United States National Library of Medicine
  • All stub articles

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id